Real-time enrollment status for this glioblastoma, idh-wildtype clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 12:37 AM UTC
| NCT Number | NCT05879250 |
| Recruiting Status | Recruiting |
| Condition | Glioblastoma, IDH-Wildtype |
| Phase | PHASE2 |
| Target Enrollment | 39 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Northwestern University |
| Last Updated on CT.gov | July 22, 2026 (Jul 22, 2026) |
As of August 30, 2026: Clinical trial NCT05879250 is currently recruiting participants. This phase2 study for glioblastoma, idh-wildtype is actively seeking new participants at 2 locations across the United States. The study is sponsored by Northwestern University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05879250 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05879250 was last updated Jul 22, 2026 (July 22, 2026). HelloStudys verifies this status automatically.